Delivery Order SPE2DB22D1017-SPE2DB24FG5UL
Award Date
9/25/24
Potential Completion Date
9/26/24
Potential Value
$1.1K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $1,081.34, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Pfizer COVID-19 vaccines in 0.9 mL doses, with an ultimate completion date of March 4, 2024. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999...
This federal contract award, valued at $1,100.15, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Pfizer COVID-19 vaccines from 2024 to 2025. The contract is a Firm Fixed Price Delivery Order with a completion date of May 21, 2025. This award is not set-aside and is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with DLA Troop Support Medical, valued at $999,999,999.00, which...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $9,856.56 firm-fixed-price delivery order is for the supply of 0.9ML Pfizer COVID-19 vaccines for the 2024-2025 period, under an Indefinite Delivery Contract (IDC) valued at $999,999,999. The award has an ultimate completion date of November 20, 2024. This contract is not designated with any set-aside requirements, indicating open competition. The...
This is a $3,389.40 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the provision of 0.9 ml Pfizer COVID-19 vaccine doses between 2024 and 2025. The award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with DLA Troop Support Medical, which serves as a primary vehicle for supplying a comprehensive range of pharmaceutical products and...
This federal contract award is for the delivery of COVID-19 vaccine doses to the Defense Logistics Agency (DLA), a component of the Department of Defense. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor that has a significant Indefinite Delivery Contract (IDC) with the DLA valued up to $999,999,999.00 through December 2025. This specific delivery order, valued at $2,171.10, is for the provision of 0.9 ML COVID-19 vaccine doses from Pfizer, covering the...
This federal contract award is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,100.15, is for the procurement of Pfizer COVID-19 vaccine doses for the 2024-2025 time period, with an ultimate completion date of April 24, 2025. The contract is a firm-fixed-price arrangement and does not have a set-aside designation. AmerisourceBergen Drug Corp holds a...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the vendor Amerisourcebergen Drug Corp, Corporate Office Division. The $1,135.77 Firm Fixed Price contract is for the delivery of Pfizer COVID vaccines in 0.9 mL doses for the 2024-2025 period, with an ultimate completion date of September 26, 2024. The award was made as a Delivery Order under an Indefinite Delivery Contract (IDC) valued at up to $999,999,999 through December 2025, which enables...
This federal contract award is a Delivery Order valued at $5,460.30 issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the procurement of Pfizer COVID-19 vaccines for the 2024-2025 timeframe, with an ultimate completion date of December 9, 2024. This award is not associated with a set-aside designation, indicating open competition. The contract is a Firm Fixed Price arrangement,...
This federal contract award is for the delivery of Pfizer COVID-19 vaccines to the Defense Logistics Agency (DLA), a defense agency of the U.S. government. The award, with a ceiling value of $1,135.77, is a delivery order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The contract provides for the supply of 0.9 mL doses of the Pfizer COVID-19 vaccine over a period of 6 months to 4 years, with an ultimate completion date...
This federal contract award is for the procurement of Pfizer COVID-19 vaccines by the Defense Logistics Agency (DLA) from AmerisourceBergen Drug Corporation. The contract, valued at $1,129.80, is a firm fixed-price delivery order with an ultimate completion date of December 24, 2024. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen, a major pharmaceutical distributor, is the prime contractor for this award, which is part of a larger Indefinite...